In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on IQVIA Holdings (IQV – Research Report), with a price ...

Truist Financial analyst Jailendra Singh reiterated a Buy rating on IQVIA Holdings (IQV – Research Report) today and set a price target of ...

Clinical research company IQVIA (NYSE: IQV) in Q4 CY2024, with sales up 2.3% year on year to $3.96 billion. On the other hand ...

IQVIA Holdings (($IQV)) has held its Q4 earnings call. Read on for the main highlights of the call. IQVIA Holdings’ recent earnings call reflected ...

IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, ...

IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...

Shares of IQVIA Holdings Inc. IQV rallied 2.20% to $209.96 Thursday, on what proved to be an all-around mixed trading session ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to ...